SELLAS Life Sciences Group, Inc.
(NASDAQ : SLS)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson -0.30%177.600.7%$1346.47m
MRKMerck & Co., Inc. 0.63%93.220.7%$1219.53m
PFEPfizer Inc. 0.92%52.120.9%$1105.35m
LLYEli Lilly & Co. 0.39%328.451.1%$1030.14m
BMYBristol-Myers Squibb Co. 0.16%76.081.0%$993.08m
ABBVAbbVie, Inc. -1.46%151.691.9%$946.25m
AZNAstraZeneca Plc 0.57%65.881.0%$473.62m
SGENSeagen Inc. -0.54%175.825.7%$324.31m
GSKGSK Plc -0.70%43.000.2%$270.50m
TPTXTurning Point Therapeutics, Inc. -0.19%75.010.0%$198.91m
HZNPHorizon Therapeutics Plc -1.03%81.915.4%$172.30m
NVSNovartis AG -1.08%83.370.2%$170.41m
ALNYAlnylam Pharmaceuticals, Inc. -0.24%150.378.1%$149.95m
MRTXMirati Therapeutics, Inc. -2.24%70.351.6%$147.44m
NVONovo Nordisk A/S -0.74%110.420.1%$147.27m

Company Profile

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline include galinpepimut-S and nelipepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.